Associate Professor Iryna Vyshnevska
L.T. Malaya Therapy National institute of NAMSU, Kharkiv (Ukraine)
Biography
PRESENT POSITION/ TITLE
Position: Senior Researcher Therapy National Institute,
CRA, Medical Study Monitor, PRESC1SE-MI, Cardiovascular Research Institute Basel, University of Basel
Title: MD, PhD, Associate Professor (academic rank)
Education:
Cardiologist high qualification category from 2023
Internal Medicine high qualification category from 2019
2013-2013 - Kharkiv medical academy of postgraduate education Cardiology № 528
2009-2011 - Kharkov National Medical University, Internal Medicine (residency)
2007-2009 -Kharkiv National Medical University,Internal Medicine (internship) № 3755
2001-2007 - Kharkiv National Medical University, General Medicine ХА № 32470069
Professional background (additional):
2010 -2022 V. N. Karazin Kharkiv National University, medical faculty, department of General and Clinical Pathology, Associate professor
Contributor content
Presentation
Prognostic value of echocardiographic parameters in predicting major adverse cardiac events one year following st-segment elevation myocardial infarction
Presentation
Predicting adverse cardiac remodeling after ST-elevation myocardial infarction with novel biomarkers soluble isoform of suppression tumorigenicity-2 and macrophage migration inhibitory factor
Presentation
HFWM: evaluating the importance of myeloperoxidase in the early anticipation of subsequent chronic heart failure occurrences in individuals after st-segment elevation acute myocardial infarction
Presentation
The predictive value of matrix metalloproteinase-9 as an inflammation marker in anticipating adverse events one year after experiencing a st-elevation myocardial infarction
Presentation
Predicting adverse cardiac remodeling following ST-elevation myocardial infarction through the assessment of endothelin-1 levels
Presentation
Evaluating the importance of myeloperoxidase in the early anticipation of subsequent chronic heart failure occurrences in individuals after st-segment elevation acute myocardial infarction
Presentation
Role of matrix metalloproteinase 9 in prediction composite one-year endpoint in st-segment elevation myocardial infarction
Presentation
Macrophage migration inhibitory factor as a predictor of left ventricle remodeling in stemi patients
Presentation
Macrophage migration inhibitory factor as a risk marker for post-infarction heart failure 6-month after st-segment elevation myocardial infarction
Presentation
